These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 14643404

  • 1. Antagonistic interactions among Fusobacterium nucleatum and Prevotella intermedia with oral lactobacilli.
    Testa MM, Ruiz de Valladares R, Benito de Cardenas IL.
    Res Microbiol; 2003 Dec; 154(10):669-75. PubMed ID: 14643404
    [Abstract] [Full Text] [Related]

  • 2. Starvation response and growth in serum of Fusobacterium nucleatum, Peptostreptococcus anaerobius, Prevotella intermedia, and Pseudoramibacter alactolyticus.
    Brundin M, Figdor D, Sundqvist G, Sjögren U.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):129-34. PubMed ID: 19540450
    [Abstract] [Full Text] [Related]

  • 3. Effects of oil drops containing Lactobacillus salivarius WB21 on periodontal health and oral microbiota producing volatile sulfur compounds.
    Suzuki N, Tanabe K, Takeshita T, Yoneda M, Iwamoto T, Oshiro S, Yamashita Y, Hirofuji T.
    J Breath Res; 2012 Mar; 6(1):017106. PubMed ID: 22368259
    [Abstract] [Full Text] [Related]

  • 4. Bacterial antagonism against periodontopathogens.
    van Essche M, Loozen G, Godts C, Boon N, Pauwels M, Quirynen M, Teughels W.
    J Periodontol; 2013 Jun; 84(6):801-11. PubMed ID: 22897652
    [Abstract] [Full Text] [Related]

  • 5. The aetiology and treatment of oral halitosis: an update.
    Lee PP, Mak WY, Newsome P.
    Hong Kong Med J; 2004 Dec; 10(6):414-8. PubMed ID: 15591601
    [Abstract] [Full Text] [Related]

  • 6. Synergy in biofilm formation between Fusobacterium nucleatum and Prevotella species.
    Okuda T, Kokubu E, Kawana T, Saito A, Okuda K, Ishihara K.
    Anaerobe; 2012 Feb; 18(1):110-6. PubMed ID: 21945879
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds.
    Kang MS, Kim BG, Chung J, Lee HC, Oh JS.
    J Clin Periodontol; 2006 Mar; 33(3):226-32. PubMed ID: 16489950
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial profiles of Prevotella spp. and Fusobacterium nucleatum isolated from periodontal infections in a selected area of southern Italy.
    Mosca A, Miragliotta L, Iodice MA, Abbinante A, Miragliotta G.
    Int J Antimicrob Agents; 2007 Dec; 30(6):521-4. PubMed ID: 17954025
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial actions of benzimidazoles against the oral anaerobes Fusobacterium nucleatum and Prevotella intermedia.
    Sheng J, Nguyen PT, Baldeck JD, Olsson J, Marquis RE.
    Arch Oral Biol; 2006 Nov; 51(11):1015-23. PubMed ID: 16806047
    [Abstract] [Full Text] [Related]

  • 10. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
    Polak D, Wilensky A, Shapira L, Halabi A, Goldstein D, Weiss EI, Houri-Haddad Y.
    J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
    [Abstract] [Full Text] [Related]

  • 11. Acid tolerance and acid-neutralizing activity of Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum.
    Takahashi N, Saito K, Schachtele CF, Yamada T.
    Oral Microbiol Immunol; 1997 Dec; 12(6):323-8. PubMed ID: 9573805
    [Abstract] [Full Text] [Related]

  • 12. Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli.
    Ryan KA, Daly P, Li Y, Hooton C, O'Toole PW.
    J Antimicrob Chemother; 2008 Apr; 61(4):831-4. PubMed ID: 18263567
    [Abstract] [Full Text] [Related]

  • 13. Comparison of culture and real-time PCR for detection and quantification of five putative periodontopathogenic bacteria in subgingival plaque samples.
    Jervøe-Storm PM, Koltzscher M, Falk W, Dörfler A, Jepsen S.
    J Clin Periodontol; 2005 Jul; 32(7):778-83. PubMed ID: 15966886
    [Abstract] [Full Text] [Related]

  • 14. Microflora in oral ecosystems in primary Sjögren's syndrome.
    Almståhl A, Wikström M, Kroneld U.
    J Rheumatol; 2001 May; 28(5):1007-13. PubMed ID: 11361180
    [Abstract] [Full Text] [Related]

  • 15. Enhanced attachment of Porphyromonas gingivalis to human fibroblasts mediated by Fusobacterium nucleatum.
    Metzger Z, Blasbalg J, Dotan M, Weiss EI.
    J Endod; 2009 Jan; 35(1):82-5. PubMed ID: 19084131
    [Abstract] [Full Text] [Related]

  • 16. Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with chronic maxillary sinusitis.
    Brook I, Yocum P.
    Ann Otol Rhinol Laryngol; 1999 Mar; 108(3):293-5. PubMed ID: 10086624
    [Abstract] [Full Text] [Related]

  • 17. Dipeptide utilization by the periodontal pathogens Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens and Fusobacterium nucleatum.
    Takahashi N, Sato T.
    Oral Microbiol Immunol; 2002 Feb; 17(1):50-4. PubMed ID: 11860556
    [Abstract] [Full Text] [Related]

  • 18. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity.
    Kõll-Klais P, Mändar R, Leibur E, Marcotte H, Hammarström L, Mikelsaar M.
    Oral Microbiol Immunol; 2005 Dec; 20(6):354-61. PubMed ID: 16238595
    [Abstract] [Full Text] [Related]

  • 19. Stimulation of Fusobacterium nucleatum biofilm formation by Porphyromonas gingivalis.
    Saito Y, Fujii R, Nakagawa KI, Kuramitsu HK, Okuda K, Ishihara K.
    Oral Microbiol Immunol; 2008 Feb; 23(1):1-6. PubMed ID: 18173791
    [Abstract] [Full Text] [Related]

  • 20. Characterization of oral lactobacilli as potential probiotics for oral health.
    Kõll P, Mändar R, Marcotte H, Leibur E, Mikelsaar M, Hammarström L.
    Oral Microbiol Immunol; 2008 Apr; 23(2):139-47. PubMed ID: 18279182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.